AARTIPHARM.BOAARTIPHARM.BOBSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+5.5%
Studio
Year-over-Year Change

Price-to-earnings ratio

3Y CAGR
+5.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
202525.08+33.8%
202418.75+45.1%
202312.92-39.5%
202221.37+101.4%
2021-1567.94-308.5%
2020-383.82-